siRNA, Anti-KIAA1217, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT71413WQ-2OMe)

The product SIRGT71413WQ-2OMe is a type of small interfering RNA (siRNA) that targets KIAA1217 gene and regulates the expression of gene. The siRNA interferes with the expression of KIAA1217 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_019590.4
Alternative Names ETL4; SKT
Related Diseases Short Syndrome
Purification HPLC
Target Gene
Gene ID 56243
Uniprot ID Q5T5P2
Sub Cat Target Species Modification Scale  
SIRGT72413WQ-2F KIAA1217 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT73413WQ-2MOE KIAA1217 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT74413WQ-LNA KIAA1217 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT71413WQ-RB KIAA1217 Human Ribo-modified Inquiry
SIRGT72413WQ-BB KIAA1217 Human Backbone-modified Inquiry

Related Products